The Board of Directors of Reneo Pharmaceuticals, Inc. has authorized a buyback plan on October 30, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | -1.85% | +16.25% | +16.25% |
May. 16 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
May. 13 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.25% | 63.17M | |
+61.00% | 55.07B | |
-1.90% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.58% | 26.28B | |
-21.12% | 18.93B | |
+6.98% | 13.03B | |
+28.20% | 12.26B | |
+26.54% | 12.21B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.